Cara Anthony tries to convince her HealthQ co-host Blake Farmer that there are benefits to embracing the caregiver identity when helping an aging parent. (Candice Evers for WPLN and KFF Health News) When his father was diagnosed with gallbladder cancer in 2025, William Morrison immediately went into caregiving mode. “We were in the hospital every
You don't have permission to access "http://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/121210" on this server. Reference #18.8877d917.1778533352.4f5a08f4 https://errors.edgesuite.net/18.8877d917.1778533352.4f5a08f4
You don't have permission to access "http://www.medpagetoday.com/opinion/climate-checkup/120877" on this server. Reference #18.8877d917.1776787361.f91a9bd https://errors.edgesuite.net/18.8877d917.1776787361.f91a9bd
You don't have permission to access "http://www.medpagetoday.com/opinion/what-we-heard/120207" on this server. Reference #18.6ef4d517.1773028971.4c0bcaf https://errors.edgesuite.net/18.6ef4d517.1773028971.4c0bcaf
5 min read WHEN THE JUSTICE Department released a trove of Epstein-related files on January 30 and then pulled down thousands of pages after redaction failures exposed victims’ identifying information and explicit material, I felt a familiar gut-drop. Once again, the people with the least power were being asked to pay twice—first for the abuse
Robert F. Kennedy Jr. has rightly made “radical transparency” the motto of his Department of Health and Human Services. HHS even has a page by that name. I think it is a good motto, and I want to help Secretary Kennedy and Acting FDA Commissioner Kyle Diamantas deliver on it in food safety, with two citizen petitions
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment